Pivotal BioSciences, Inc. is an emerging company dedicated to the development and commercialization of innovative cancer therapies.

Breakthroughs in the basic understanding of the immune system, combined with powerful new biotechnological tools, have provided the foundation for new, rational, and technologically sophisticated approaches to immunotherapy.

The product candidates developed by Pivotal’s distinguished founders were discovered at the University of Southern California Keck School of Medicine. Pivotal's strategy is to initiate early-stage clinical trials and then obtain commercialization partners to complete advanced clinical trials, obtain FDA approval, manufacture and market its highly promising drug candidates.